EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Prime Medicine's enterprise value is $664.28 Mil.
Prime Medicine's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.59 Mil. Therefore, Prime Medicine's EV-to-Revenue for today is 1,124.00.
The historical rank and industry rank for Prime Medicine's EV-to-Revenue or its related term are showing as below:
PRME'
s EV-to-Revenue Range Over the Past 10 Years
Min: 499.72 Med: 719.79 Max: 969.02
Current: 1124
During the past 4 years, the highest EV-to-Revenue of Prime Medicine was 969.02. The lowest was 499.72. And the median was 719.79.
PRME's EV-to-Revenue is ranked worse than 95% of 1039
companies
in the Biotechnology industry
Industry Median: 8.18
vs PRME: 1124.00
As of today (2024-05-26), Prime Medicine's stock price is $6.925.
Prime Medicine's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.01. Therefore, Prime Medicine's PS Ratio for today is 1,154.17.
Prime Medicine EV-to-Revenue Historical Data
The historical data trend for Prime Medicine's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Prime Medicine's EV-to-Revenue
For the Biotechnology subindustry, Prime Medicine's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prime Medicine's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Prime Medicine's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Prime Medicine's EV-to-Revenue falls into.
Prime Medicine's current Enterprise Value is $664.28 Mil.
Prime Medicine's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.59 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prime Medicine (NAS:PRME) EV-to-Revenue Explanation
Prime Medicine's share price for today is $6.925.
Prime Medicine's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prime Medicine EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Prime Medicine's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Prime Medicine (Prime Medicine) Business Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRME has been successfully added to your 